319 related articles for article (PubMed ID: 31062625)
21. High drug loading and pH-responsive targeted nanocarriers from alginate-modified SPIONs for anti-tumor chemotherapy.
Peng N; Wu B; Wang L; He W; Ai Z; Zhang X; Wang Y; Fan L; Ye Q
Biomater Sci; 2016 Nov; 4(12):1802-1813. PubMed ID: 27792228
[TBL] [Abstract][Full Text] [Related]
22. Supercritically dried superparamagnetic mesoporous silica nanoparticles for cancer theranostics.
Vaz-Ramos J; Cordeiro R; Castro MMCA; Geraldes CFGC; Costa BFO; Faneca H; Durães L
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111124. PubMed ID: 32600723
[TBL] [Abstract][Full Text] [Related]
23. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
[TBL] [Abstract][Full Text] [Related]
24. Papain grafted into the silica coated iron-based magnetic nanoparticles 'IONPs@SiO
Nasiri R; Dabagh S; Meamar R; Idris A; Muhammad I; Irfan M; Rashidi Nodeh H
Nanotechnology; 2020 May; 31(19):195603. PubMed ID: 31978907
[TBL] [Abstract][Full Text] [Related]
25. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
26. Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment.
Martínez-Carmona M; Lozano D; Colilla M; Vallet-Regí M
Acta Biomater; 2018 Jan; 65():393-404. PubMed ID: 29127069
[TBL] [Abstract][Full Text] [Related]
27. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
28. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
29. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
30. Folate receptor-mediated delivery of 1-MDT-loaded mesoporous silica magnetic nanoparticles to target breast cancer cells.
Hashemzadeh N; Dolatkhah M; Aghanejad A; Barzegar-Jalali M; Omidi Y; Adibkia K; Barar J
Nanomedicine (Lond); 2021 Oct; 16(24):2137-2154. PubMed ID: 34530630
[No Abstract] [Full Text] [Related]
31. Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer.
Nabi PN; Vahidfar N; Tohidkia MR; Hamidi AA; Omidi Y; Aghanejad A
Int J Biol Macromol; 2021 Mar; 174():185-197. PubMed ID: 33516855
[TBL] [Abstract][Full Text] [Related]
32. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
33. Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles.
Hashemzadeh N; Aghanejad A; Dalir Abdolahinia E; Dolatkhah M; Barzegar-Jalali M; Omidi Y; Barar J; Adibkia K
J Microencapsul; 2021; 38(7-8):472-485. PubMed ID: 34511038
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro.
Li S; Zhang Y; He XW; Li WY; Zhang YK
Talanta; 2020 Mar; 209():120552. PubMed ID: 31892096
[TBL] [Abstract][Full Text] [Related]
35. Functionalization of Magnetic Nanoparticles by Folate as Potential MRI Contrast Agent for Breast Cancer Diagnostics.
Heydari Sheikh Hossein H; Jabbari I; Zarepour A; Zarrabi A; Ashrafizadeh M; Taherian A; Makvandi P
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899812
[TBL] [Abstract][Full Text] [Related]
36. Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.
Abedi M; Abolmaali SS; Abedanzadeh M; Farjadian F; Mohammadi Samani S; Tamaddon AM
Int J Nanomedicine; 2020; 15():2617-2631. PubMed ID: 32368044
[TBL] [Abstract][Full Text] [Related]
37. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
38. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.
Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS
J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867
[TBL] [Abstract][Full Text] [Related]
39. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
40. Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy.
Sun X; Liu B; Chen X; Lin H; Peng Y; Li Y; Zheng H; Xu Y; Ou X; Yan S; Wu Z; Deng S; Zhang L; Zhao P
J Mater Sci Mater Med; 2019 Jun; 30(7):76. PubMed ID: 31218573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
